Status Approved
First Submitted Date
2017/07/25
Registered Date
2017/11/17
Last Updated Date
2017/11/01
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0002541 |
---|---|
Unique Protocol ID | ED16199 |
Public/Brief Title | Study for diagnostic accuracy of dual capsule endoscopy |
Scientific Title | Prospective study for comparison of detetion rate for AOV between dual capsule endoscopy and single capsuel endoscopy |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | ED16199 |
Approval Date | 2016-09-12 |
Institutional Review Board Name | Korea University Anam Hospital Institutional review board |
Institutional Review Board Address | |
Institutional Review Board Telephone | |
Data Monitoring Committee |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Seung Han Kim |
Title | M.D., Ph.D. |
Telephone | +82-2-920-6555 |
Affiliation | Korea University Anam Hospital |
Address | Anam-dong 5 ga, Seongbuk-gu, Seoul 02841, Republic of Korea. |
Contact Person for Public Queries | |
Name | Seung Han Kim |
Title | M.D., Ph.D. |
Telephone | +82-2-920-6555 |
Affiliation | Korea University Anam Hospital |
Address | Anam-dong 5 ga, Seongbuk-gu, Seoul 02841, Republic of Korea. |
Contact Person for Updating Information | |
Name | Seung Han Kim |
Title | M.D., Ph.D. |
Telephone | +82-2-920-6555 |
Affiliation | Korea University Anam Hospital |
Address | Anam-dong 5 ga, Seongbuk-gu, Seoul 02841, Republic of Korea. |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Recruiting | |
Date of First Enrollment | 2017-07-18 Actual | |
Target Number of Participant | 50 | |
Primary Completion Date | ||
Study Completion Date | ||
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Korea University | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2017-07-18 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Ministry of Trade, Industry & Energy |
Organization Type | Government |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Korea University |
Organization Type | University |
7. Study Summary
Lay Summary | Capsule endoscopy (CE) is a noninvasive option for investigating the small bowel disorder. However, several studies have reported that the visualization of the small intestine with CE is suboptimal. In the present study, we aimed to evaluate the diagnostic ability of dual CE examination. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Diagnosis |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Double |
Blinded Subject | Subject, Investigator |
Allocation | RCT |
Intervention Type | Medical Device |
Intervention Description | Comparative Analysis of Single and Double Doses of Capsule Endoscopy |
Number of Arms | 2 |
Arm 1 |
Arm Label Comparative Analysis of Double Doses of Capsule Endoscopy |
Target Number of Participant 25 |
|
Arm Type Experimental |
|
Arm Description Two capsule endoscopes were administered simultaneously to determine the lesion detection rate |
|
Arm 2 |
Arm Label Comparative Analysis of single Dose of Capsule Endoscopy |
Target Number of Participant 25 |
|
Arm Type Active comparator |
|
Arm Description one capsule endoscope were administered simultaneously to determine the lesion detection rate |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (R00-R99)Symptoms, signs and abnormal clinical and laboratory findings, NEC (R10.49)Unspecified abdominal pain |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 18Year~80Year |
|
Description OGIB, chronic diarrhea, and chronic abdominal pain |
|
Exclusion Criteria |
small bowel stenosis, swallowing difficulties, severe advanced respiratory disease, or cardiovascular or neuropsychiatric disease. Pregnant patients and those with implantable electronic devices were also excluded. |
Healthy Volunteers |
10. Outcome Measure(s)
Type of Primary Outcome | /Safety/Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | detection rate of small bowel lesion |
|
Timepoint | after 24hours |
|
Secondary Outcome(s) 1 | ||
Outcome | adverse events |
|
Timepoint | after 24hours |
11. Study Results and Publication
Result Registered |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | Not provided at time of Registration |
---|
TOP
BOTTOM
화면 최하단으로 이동